Scientists probe Melanoma's metabolic escape from immunotherapy
NCT ID NCT05307289
First seen Jan 03, 2026 · Last updated May 13, 2026 · Updated 20 times
Summary
This study looks at why some melanomas stop responding to immunotherapy. Researchers will analyze tumor samples from 20 patients before and after treatment to see how the cancer's energy use changes. The goal is to find new ways to target resistant tumors without harming immune cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice
RECRUITINGNice, Alpes-maritimes, 06001, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.